<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02696369</url>
  </required_header>
  <id_info>
    <org_study_id>HU-015</org_study_id>
    <nct_id>NCT02696369</nct_id>
  </id_info>
  <brief_title>Trial to Evaluate the Efficacy on Local Anesthesia and Safety of 2% Lidocaine HCl With Different Epinephrine Concentration in Patients Undergoing Surgical Extraction of Impacted Lower Third Molars</brief_title>
  <official_title>A Multi-center, Randomized, Double-blind, Crossover, phase4 Trial to Evaluate the Efficacy on Local Anesthesia and Safety of 2% Lidocaine HCl With Different Epinephrine Concentration in Patients Undergoing Surgical Extraction of Impacted Lower Third Molars</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huons Co.,Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Huons Co.,Ltd.</source>
  <brief_summary>
    <textblock>
      This study is Phase 4 trial which evaluates the safety and efficacy of 2% Lidocaine HCl with
      different epinephrine concentration in patients undergoing surgical extraction of impacted
      lower third molars
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain visual analogue scale (VAS)</measure>
    <time_frame>Immediately after the extraction</time_frame>
    <description>To acess the pain immediately after the surgical extraction of impacted lower third molars</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Onset time of anesthesia</measure>
    <time_frame>Immediately after administration of IP</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Local anesthetic duration</measure>
    <time_frame>Immediately after onset of anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain VAS</measure>
    <time_frame>2, 4, 6 hours after administration of the investigational product (IP)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Onset time of pain after administration of IP</measure>
    <time_frame>Immediately after injection</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding after extraction measured by the operator</measure>
    <time_frame>Immediately after extraction</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire of satisfaction level of the operator</measure>
    <time_frame>Immediately after extraction</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire of satisfaction level of the subjects</measure>
    <time_frame>Immediately after extraction</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dosage of administrated IP</measure>
    <time_frame>immediately after injection</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">65</enrollment>
  <condition>Third Molar</condition>
  <arm_group>
    <arm_group_label>2% Lidocaine HCL:Epinephrine inj.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2% Lidocaine HCL with epinephrine 1:200,000</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2% Lidocaine HCL:Epinephrine inj. (3M)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2% Lidocaine HCl with epinephrine 1:80,000</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2% lidocaine HCl with epinephrine 1:200,000</intervention_name>
    <arm_group_label>2% Lidocaine HCL:Epinephrine inj.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2% lidocaine HCl with epinephrine 1:80,000</intervention_name>
    <arm_group_label>2% Lidocaine HCL:Epinephrine inj. (3M)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 19

          -  Physical grade 1 or 2 by American Society of Anesthesiologists (ASA)

          -  Mesioangular or horizontal angulation categorized by winter classification

        Exclusion Criteria:

          -  Allergy or hypersensitivity about the investigated products

          -  Any infection or edema during the extraction

          -  The following patients: clotting disorder, hyperthyroidism, arteriosclerosis, cardiac
             insufficiency, other cardiovascular disorders

          -  Pregnancy or breast-feeding

          -  Any conditions that the investigator considers not to appropriate for this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Huons</name>
      <address>
        <city>Ansan</city>
        <state>Kyeonggi-do</state>
        <zip>426791</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2016</study_first_submitted>
  <study_first_submitted_qc>March 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2016</study_first_posted>
  <last_update_submitted>March 1, 2016</last_update_submitted>
  <last_update_submitted_qc>March 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

